In this issue:
Bosutinib in chronic phase Ph+ CML
Chromosomal instability with G-CSF in healthy PBSC donors
Pegylated interferon-α2b + imatinib improves MMR in CML
ELN response definitions don’t apply to 2nd-generation TKIs
High-dose cyclophosphamide + rituximab without SCT in indolent NHL
BEACOPPesc followed by standard BEACOPP, ±RT, in advanced HL
Treating limited-stage NLPHL with ABVD
Epratuzumab + R-CHOP in DLBCL
R-CHOP every 2 vs. 3 weeks for indolent B-cell NHL
SMILE for ENKL
Please login below to download this issue (PDF)